Phosphoinositide 3-kinase in disease: timing, location, and scaffolding

Matthias P Wymann1, Romina Marone

  • 1Inst. Biochemistry and Genetics, Dept. Clinical and Biological Sciences, Centre of Biomedicine, University of Basel, Mattenstrasse 28, CH-4058, Basel. Matthias.Wymann@UniBas.CH

Insights

Dereguled phosphoinositide 3-kinases (PI3Ks) cause disease by increasing cell growth and motility. PI3Kgamma

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Background:

  • Phosphoinositide 3-kinases (PI3Ks) pathway deregulation, marked by phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P3) accumulation, drives increased cell growth, proliferation, and survival.
  • The PI3K/PKB/TOR signaling axis is crucial for regulating protein synthesis and cell growth.
  • PtdIns(3,4,5)P3 also activates Rho GTPases, influencing cell motility, and PI3K activity is implicated in various diseases including cancer, inflammation, and cardiovascular conditions.

Purpose of the Study:

  • To investigate the specific roles of PI3K isoforms in disease pathogenesis.
  • To elucidate the precise function of PI3Kgamma in cellular processes, particularly in the cardiac system.

Main Methods:

  • Analysis of PI3K signaling pathways and PtdIns(3,4,5)P3 accumulation.
  • Investigation of the PI3K/PKB/TOR axis in cell growth and proliferation.
  • Examination of Rho GTPase activation and its role in cell motility.
  • Specific studies on PI3Kgamma's function in the cardiac system, assessing its lipid kinase activity and scaffolding role.

Main Results:

  • Aberrant PI3K activity leads to PtdIns(3,4,5)P3 accumulation, promoting cell growth, proliferation, and survival.
  • The PI3K/PKB/TOR pathway is confirmed to control protein synthesis and growth.
  • PtdIns(3,4,5)P3-mediated activation of Rho GTPases is shown to direct cell motility.
  • Recent findings indicate PI3Kgamma acts as a scaffold protein in the cardiac system, regulating cAMP levels, but does not function as a lipid kinase in this context.

Conclusions:

  • While increased PtdIns(3,4,5)P3 is a known disease driver, identifying the implicated PI3K isoform remains challenging.
  • PI3Kgamma's role in the cardiac system is primarily structural (scaffolding) rather than enzymatic (lipid kinase), impacting cAMP regulation.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Disassembly of Intermediate Filaments01:35

Disassembly of Intermediate Filaments

Intermediate filaments (IFs) do not undergo spontaneous disassembly. Enzymes, kinases, and phosphatases add and remove phosphates from specific sites to regulate their disassembly. The IF concentration in the cytoplasm also regulates the disassembly. If the concentration crosses a threshold, it activates the protein kinases in the vicinity, allowing the phosphorylation of IFs.
Keratin proteins, found at the cell periphery near cell junctions, undergo a cycle of assembly and disassembly. In Type...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...